Aflibercept in wet age-related macular degeneration: a perspective review

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

(2012) Nicholas Papadopoulos et al.   ANGIOGENESIS

Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File

(2011) Ross J. Brechner et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Prevention of Experimental Choroidal Neovascularization and Resolution of Active Lesions by VEGF Trap in Nonhuman Primates

(2011) T. Michael Nork   ARCHIVES OF OPHTHALMOLOGY

Prevalence of Age-Related Macular Degeneration in the US Population

(2011) Ronald Klein   ARCHIVES OF OPHTHALMOLOGY

Treatment for atrophic macular degeneration

(2011) Annal D Meleth et al.   CURRENT OPINION IN OPHTHALMOLOGY

Regulation of VEGF expression in human retinal cells by cytokines: Implications for the role of inflammation in age-related macular degeneration

(2011) Chandrasekharam N. Nagineni et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Sustained Increased Intraocular Pressure Related to Intravitreal Antivascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration

(2011) Joseph J. Tseng et al.   JOURNAL OF GLAUCOMA

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Primary Endpoint Results of a Phase II Study of Vascular Endothelial Growth Factor Trap-Eye in Wet Age-related Macular Degeneration

(2011) David M. Brown et al.   OPHTHALMOLOGY

The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing

(2011) Jeffrey S. Heier et al.   OPHTHALMOLOGY

INJECT AND EXTEND DOSING VERSUS DOSING AS NEEDED

(2010) Hassiba Oubraham et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

(2009) Geeta A. Lalwani et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration

(2009) James A Dixon et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

A Phase I Study of Intravitreal Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular Age-Related Macular Degeneration

(2009) Quan Dong Nguyen et al.   OPHTHALMOLOGY

“TREAT AND EXTEND” DOSING OF INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR TYPE 3 NEOVASCULARIZATION/RETINAL ANGIOMATOUS PROLIFERATION

(2009) MICHAEL ENGELBERT et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

(2008) Carl D. Regillo et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Predicted biological activity of intravitreal VEGF Trap

(2008) M W Stewart et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

(2008) David M. Brown et al.   OPHTHALMOLOGY

Age-related maculopathy – Linking aetiology and pathophysiological changes to the ischaemia hypothesis

(2008) Beatrix Feigl   PROGRESS IN RETINAL AND EYE RESEARCH

Aflibercept

(2008) &NA;   Drugs in research & development